Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Research Abstract |
Knockdown of CTGF with specific small interfering RNAs in OVISE cells, the ovarian clear cell carcinoma cell line, and in OVSAHO cells, the ovarian serous carcinoma cell line enhanced resistance to apoptosis on exposure to paclitaxel, but not enhanced resistance to apotosis on exposure to carboplatin, cisplatin and doxorubicin.
|